ConductScience.org, home

Paper42005706

Innovative Applications of Nanomaterials in the Diagnosis and Treatment of Ocular Diseases: Targeted Delivery, Intelligent Therapy, Diagnostic Breakthroughs, and Synergistic Strategies with Stem Cells and Biomaterials.

Su G and 1 other. Int J Nanomedicine, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Innovative Applications of Nanomaterials in the Diagnosis and Treatment of Ocular Diseases: Targeted Delivery, Intelligent Therapy, Diagnostic Breakthroughs, and Synergistic Strategies with Stem Cells and Biomaterials. Papers, record 42005706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42005706

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Innovative Applications of Nanomaterials in the Diagnosis and Treatment of Ocular Diseases: Targeted Delivery, Intelligent Therapy, Diagnostic Breakthroughs, and Synergistic Strategies with Stem Cells and Biomaterials.
PubMed
Journal
Int J Nanomedicine
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Su GGuanyuhttps://orcid.org/0000-0003-2740-2360
2Xu WWeixing

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Eye DiseasesMajor topic
Stem Cell TransplantationMajor topic
NanostructuresMajor topic
Biocompatible MaterialsMajor topic
Drug Delivery SystemsMajor topic
Humans
Animals
Artificial Intelligence
Nanomedicine

Source PubMed

Download CSV of topics

References187

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139543615Microneedle patches incorporating zinc-doped mesoporous silica nanoparticles loaded with betamethasone dipropionate for psoriasis treatment.J Nanobiotechnology2024https://conductscience.org/library/papers/39543615PubMed
232765614Corneal Stem Cells as a Source of Regenerative Cell-Based Therapy.Stem Cells Int2020https://conductscience.org/library/papers/32765614PubMed
336461689Functional Carbon Quantum Dots for Ocular Imaging and Therapeutic Applications.Small2023https://conductscience.org/library/papers/36461689PubMed
440126731Advances in the study of single-walled carbon nanotubes in ophthalmology.Hum Cell2025https://conductscience.org/library/papers/40126731PubMed
539093514Carbon quantum dots for the diagnosis and treatment of ophthalmic diseases.Hum Cell2024https://conductscience.org/library/papers/39093514PubMed
637591463Lipid-based nanocarriers challenging the ocular biological barriers: Current paradigm and future perspectives.J Control Release2023https://conductscience.org/library/papers/37591463PubMed
739512331Nanotechnology in retinal diseases: From disease diagnosis to therapeutic applications.Biophys Rev (Melville)2024https://conductscience.org/library/papers/39512331PubMed
837433372Nanomaterial-based ophthalmic drug delivery.Adv Drug Deliv Rev2023https://conductscience.org/library/papers/37433372PubMed
937480102Nanotechnology-based ocular drug delivery systems: recent advances and future prospects.J Nanobiotechnology2023https://conductscience.org/library/papers/37480102PubMed
1038136724Nanoparticles and Their Antibacterial Application in Endodontics.Antibiotics (Basel)2023https://conductscience.org/library/papers/38136724PubMed
1140718639Nanomedicine-Based Ophthalmic Drug Delivery Systems for the Treatment of Ocular Diseases.Int J Nanomedicine2025https://conductscience.org/library/papers/40718639PubMed
1234200251Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges.Pharmaceutics2021https://conductscience.org/library/papers/34200251PubMed
1338927641Inherited Retinal Diseases and Retinal Organoids as Preclinical Cell Models for Inherited Retinal Disease Research.Genes (Basel)2024https://conductscience.org/library/papers/38927641PubMed
1435185587Tacrolimus Loaded Cationic Liposomes for Dry Eye Treatment.Front Pharmacol2022https://conductscience.org/library/papers/35185587PubMed
1533804932Mixed Pluronic-Cremophor Polymeric Micelles as Nanocarriers for Poorly Soluble Antibiotics-The Influence on the Antibacterial Activity.Pharmaceutics2021https://conductscience.org/library/papers/33804932PubMed
1637896180Subconjunctival Delivery of Sorafenib-Tosylate-Loaded Cubosomes for Facilitated Diabetic Retinopathy Treatment: Formulation Development, Evaluation, Pharmacokinetic and Pharmacodynamic (PKPD) Studies.Pharmaceutics2023https://conductscience.org/library/papers/37896180PubMed
1739422807Retinal Organoids from Induced Pluripotent Stem Cells of Patients with Inherited Retinal Diseases: A Systematic Review.Stem Cell Rev Rep2025https://conductscience.org/library/papers/39422807PubMed
1838720321Dual-ROS-scavenging and dual-lingering nanozyme-based eye drops alleviate dry eye disease.J Nanobiotechnology2024https://conductscience.org/library/papers/38720321PubMed
1935319035Molecular insights into the resistance of phospholipid heads to the membrane penetration of graphene nanosheets.Nanoscale2022https://conductscience.org/library/papers/35319035PubMed
2021128727Preliminary evaluation of a nanotechnology-based approach for the more effective diagnosis of colon cancers.Nanomedicine (Lond)2010https://conductscience.org/library/papers/21128727PubMed

See all 187 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42797356Nanoformulations for Ocular Drug Delivery in Glaucoma: From Metal-Based Nanoparticles to Advanced Nanocarriers.Pharmaceutics2026https://conductscience.org/library/papers/42797356

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42005706

GET https://conductscience.org/api/papers/v1/42005706/references?page=2